Hunan Jingfeng Pharmaceutical Hits Day Low Amid Price Pressure at CNY 6.02

Hunan Jingfeng Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 5.27% as it reached an intraday low of CNY 6.02. This performance stands in contrast to the China Shanghai Composite, which saw a minor decrease of 0.11% on the same day. Over the past week, Hunan Jingfeng has faced a more pronounced downturn, with a 10.01% decline, while the broader market has gained 2.04%. The one-month performance reflects a substantial drop of 21.97%, further highlighting the stock's struggles compared to the market's slight decrease of 1.05%. Year-to-date, Hunan Jingfeng's performance has been notably negative, with a decline of 15.02%, contrasting sharply with the China Shanghai Composite's gain of 3.1%. Despite a positive return of 4.8% over the past year, this figure is significantly lower than the market's robust 20.75% return. The company's financial metrics indicate challenges, including a net profit of CNY -32.65 million and an operating cash flow of CNY -23.68 million, suggesting a difficult operating environment. As a large-cap player in the pharmaceuticals and biotechnology sector, Hunan Jingfeng's recent performance underscores the complexities it faces in the current market landscape.